These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 10330143)

  • 1. Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors.
    Yang SH; Galanis A; Sharrocks AD
    Mol Cell Biol; 1999 Jun; 19(6):4028-38. PubMed ID: 10330143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the MEF2 family of transcription factors by p38.
    Zhao M; New L; Kravchenko VV; Kato Y; Gram H; di Padova F; Olson EN; Ulevitch RJ; Han J
    Mol Cell Biol; 1999 Jan; 19(1):21-30. PubMed ID: 9858528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-translational control of the MEF2A transcriptional regulatory protein.
    Ornatsky OI; Cox DM; Tangirala P; Andreucci JJ; Quinn ZA; Wrana JL; Prywes R; Yu YT; McDermott JC
    Nucleic Acids Res; 1999 Jul; 27(13):2646-54. PubMed ID: 10373581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: a role for c-Jun NH2-terminal kinase, p38s, and extracellular signal-regulated kinase 5.
    Marinissen MJ; Chiariello M; Pallante M; Gutkind JS
    Mol Cell Biol; 1999 Jun; 19(6):4289-301. PubMed ID: 10330170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1.
    Yang SH; Whitmarsh AJ; Davis RJ; Sharrocks AD
    EMBO J; 1998 Mar; 17(6):1740-9. PubMed ID: 9501095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation.
    Han J; Jiang Y; Li Z; Kravchenko VV; Ulevitch RJ
    Nature; 1997 Mar; 386(6622):296-9. PubMed ID: 9069290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade.
    Enslen H; Tokumitsu H; Stork PJ; Davis RJ; Soderling TR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10803-8. PubMed ID: 8855261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity determinants in MAPK signaling to transcription factors.
    Barsyte-Lovejoy D; Galanis A; Sharrocks AD
    J Biol Chem; 2002 Mar; 277(12):9896-903. PubMed ID: 11786537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation.
    Sugimoto T; Stewart S; Han M; Guan KL
    EMBO J; 1998 Mar; 17(6):1717-27. PubMed ID: 9501093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors.
    Whitmarsh AJ; Yang SH; Su MS; Sharrocks AD; Davis RJ
    Mol Cell Biol; 1997 May; 17(5):2360-71. PubMed ID: 9111305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps.
    Wu Z; Woodring PJ; Bhakta KS; Tamura K; Wen F; Feramisco JR; Karin M; Wang JY; Puri PL
    Mol Cell Biol; 2000 Jun; 20(11):3951-64. PubMed ID: 10805738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypotonicity activates transcription through ERK-dependent and -independent pathways in renal cells.
    Zhang Z; Yang XY; Cohen DM
    Am J Physiol; 1998 Oct; 275(4):C1104-12. PubMed ID: 9755064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective response of ternary complex factor Sap1a to different mitogen-activated protein kinase subgroups.
    Strahl T; Gille H; Shaw PE
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11563-8. PubMed ID: 8876175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convergence of MAP kinase pathways on the ternary complex factor Sap-1a.
    Janknecht R; Hunter T
    EMBO J; 1997 Apr; 16(7):1620-7. PubMed ID: 9130707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1.
    Yang CC; Ornatsky OI; McDermott JC; Cruz TF; Prody CA
    Nucleic Acids Res; 1998 Oct; 26(20):4771-7. PubMed ID: 9753748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ternary complex factor Net contains two distinct elements that mediate different responses to MAP kinase signalling cascades.
    Ducret C; Maira SM; Lutz Y; Wasylyk B
    Oncogene; 2000 Oct; 19(44):5063-72. PubMed ID: 11042694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular smooth muscle cell proliferation requires both p38 and BMK1 MAP kinases.
    Zhao M; Liu Y; Bao M; Kato Y; Han J; Eaton JW
    Arch Biochem Biophys; 2002 Apr; 400(2):199-207. PubMed ID: 12054430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates following quinolinic acid excitotoxicity in the rat.
    Ferrer I; Blanco R; Carmona M
    Brain Res Mol Brain Res; 2001 Oct; 94(1-2):48-58. PubMed ID: 11597764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motif.
    Barsyte-Lovejoy D; Galanis A; Clancy A; Sharrocks AD
    Biochem J; 2004 Aug; 381(Pt 3):693-9. PubMed ID: 15132737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
    Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
    Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.